The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Viral Vector Manufacturing-Global Market Insights and Sales Trends 2025
Synopsis
Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
The global Viral Vector Manufacturing market size is expected to reach US$ 678.8 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Vector Manufacturing in various end use industries. The expanding demands from the Gene Therapy and Vaccinology, are propelling Viral Vector Manufacturing market. Adenoviral Vectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adeno-associated Viral Vectors segment is estimated at % CAGR for the next seven-year period.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vector Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Vector Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vector Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vector Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vector Manufacturing covered in this report include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies and Lonza, etc.
The global Viral Vector Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)
Global Viral Vector Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vector Manufacturing market, Segment by Type:
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other
Global Viral Vector Manufacturing market, by Application
Gene Therapy
Vaccinology
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Vector Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
The global Viral Vector Manufacturing market size is expected to reach US$ 678.8 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Vector Manufacturing in various end use industries. The expanding demands from the Gene Therapy and Vaccinology, are propelling Viral Vector Manufacturing market. Adenoviral Vectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adeno-associated Viral Vectors segment is estimated at % CAGR for the next seven-year period.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vector Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Vector Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vector Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vector Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vector Manufacturing covered in this report include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies and Lonza, etc.
The global Viral Vector Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)
Global Viral Vector Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vector Manufacturing market, Segment by Type:
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other
Global Viral Vector Manufacturing market, by Application
Gene Therapy
Vaccinology
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Vector Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Viral Vector Manufacturing
1.1 Viral Vector Manufacturing Market Overview
1.1.1 Viral Vector Manufacturing Product Scope
1.1.2 Viral Vector Manufacturing Market Status and Outlook
1.2 Global Viral Vector Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Vector Manufacturing Market Size by Region (2018-2029)
1.4 Global Viral Vector Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Viral Vector Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Vector Manufacturing Market Size (2018-2029)
1.6.1 North America Viral Vector Manufacturing Market Size (2018-2029)
1.6.2 Europe Viral Vector Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Vector Manufacturing Market Size (2018-2029)
1.6.4 Latin America Viral Vector Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Vector Manufacturing Market Size (2018-2029)
2 Viral Vector Manufacturing Market by Type
2.1 Introduction
2.1.1 Adenoviral Vectors
2.1.2 Adeno-associated Viral Vectors
2.1.3 Retroviral Vectors
2.1.4 Lentiviral Vectors
2.1.5 Other
2.2 Global Viral Vector Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Vector Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
3 Viral Vector Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Gene Therapy
3.1.2 Vaccinology
3.2 Global Viral Vector Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Vector Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
4 Viral Vector Manufacturing Competition Analysis by Players
4.1 Global Viral Vector Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2022)
4.3 Date of Key Players Enter into Viral Vector Manufacturing Market
4.4 Global Top Players Viral Vector Manufacturing Headquarters and Area Served
4.5 Key Players Viral Vector Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Vector Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioReliance
5.1.1 BioReliance Profile
5.1.2 BioReliance Main Business
5.1.3 BioReliance Viral Vector Manufacturing Products, Services and Solutions
5.1.4 BioReliance Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 BioReliance Recent Developments
5.2 Cobra Biologics
5.2.1 Cobra Biologics Profile
5.2.2 Cobra Biologics Main Business
5.2.3 Cobra Biologics Viral Vector Manufacturing Products, Services and Solutions
5.2.4 Cobra Biologics Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Cobra Biologics Recent Developments
5.3 Oxford BioMedica
5.3.1 Oxford BioMedica Profile
5.3.2 Oxford BioMedica Main Business
5.3.3 Oxford BioMedica Viral Vector Manufacturing Products, Services and Solutions
5.3.4 Oxford BioMedica Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 UniQure Recent Developments
5.4 UniQure
5.4.1 UniQure Profile
5.4.2 UniQure Main Business
5.4.3 UniQure Viral Vector Manufacturing Products, Services and Solutions
5.4.4 UniQure Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 UniQure Recent Developments
5.5 FinVector
5.5.1 FinVector Profile
5.5.2 FinVector Main Business
5.5.3 FinVector Viral Vector Manufacturing Products, Services and Solutions
5.5.4 FinVector Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 FinVector Recent Developments
5.6 MolMed
5.6.1 MolMed Profile
5.6.2 MolMed Main Business
5.6.3 MolMed Viral Vector Manufacturing Products, Services and Solutions
5.6.4 MolMed Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 MolMed Recent Developments
5.7 MassBiologics
5.7.1 MassBiologics Profile
5.7.2 MassBiologics Main Business
5.7.3 MassBiologics Viral Vector Manufacturing Products, Services and Solutions
5.7.4 MassBiologics Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 MassBiologics Recent Developments
5.8 FUJIFILM Diosynth Biotechnologies
5.8.1 FUJIFILM Diosynth Biotechnologies Profile
5.8.2 FUJIFILM Diosynth Biotechnologies Main Business
5.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Products, Services and Solutions
5.8.4 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Viral Vector Manufacturing Products, Services and Solutions
5.9.4 Lonza Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 Biovian
5.10.1 Biovian Profile
5.10.2 Biovian Main Business
5.10.3 Biovian Viral Vector Manufacturing Products, Services and Solutions
5.10.4 Biovian Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Biovian Recent Developments
5.11 Thermo Fisher Scientific (Brammer Bio)
5.11.1 Thermo Fisher Scientific (Brammer Bio) Profile
5.11.2 Thermo Fisher Scientific (Brammer Bio) Main Business
5.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Products, Services and Solutions
5.11.4 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
6 North America
6.1 North America Viral Vector Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Vector Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Vector Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Vector Manufacturing Market Dynamics
11.1 Viral Vector Manufacturing Industry Trends
11.2 Viral Vector Manufacturing Market Drivers
11.3 Viral Vector Manufacturing Market Challenges
11.4 Viral Vector Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
